https://www.selleckchem.com/pr....oducts/n6-methyladen
0001) with wide heterogeneity ( = 89.7%); subgroup analysis on venous thrombosis only changed neither effect size ( 0.0001) nor heterogeneity ( = 72.7%). BD participants with ocular involvement had higher HC than those without ( 0.0001) with moderate heterogeneity ( = 40.3%). Although causality cannot be inferred, the consistency of the elevation of plasma HC in BD, particularly in patients with active disease, with vascular and ocular involvement suggests an intrinsic involvement of HC in these clinical manif
Like
Comment
Share
